NSE
Alivus Life Sciences LimitedALIVUS
Alivus Life Sciences Limited is a company focused on high-growth opportunities in the pharmaceutical sector, recently posting healthy Q3 results with a 10% YoY increase in PAT.
| Key products | Pharmaceutical products and segments |
|---|---|
| Geography | India |
| Competitors | Nirma Limited |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 5 Per Share
ex 2025-09-01
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | ALIVUSThis | — | — | — | — | +2 | 6 |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
Timeline — ALIVUS day by day
- 2026-06-12FilingNirma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Shareholding Disclosure
- 2026-06-12NewsNirma Limited confirms no encumbrance on Alivus Life Sciences shares in FY26scanx.trade
- 2026-06-10FilingAlivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/ Institutional Investor meetiInvestor Call
- 2026-06-10NewsAlivus Life Sciences schedules investor meet for June 16scanx.trade
- 2026-05-25NewsStock Stories: How Alivus Life Sciences is Formulating a High-Growth Future Beyond Traditional PharmaMarketSmith India
- 2026-01-23NewsAlivus Life Sciences gains 5% on posting healthy Q3 results; PAT up 10%YoYBusiness Standard
- 2025-11-23NewsALIVUS LIFE SCIENCES LTD Share Price Today - Live ALIVUS Stock Price for NSE/BSEUpstox
- 2025-09-01ActionDividend - Rs 5 Per ShareDividend
- 2025-01-03NewsAlivus Life Sciences Ltd Share Price Today | Alivus Life Sciences Live NSE/BSEValue Research
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 3
No bulk/block deals for ALIVUS in this window.
Results & transcripts
Financial results
None yet.
News & chatter on ALIVUS
RSS News
6scanx.trade · 13/6/2026
scanx.trade · 10/6/2026
▲MarketSmith India · 25/5/2026
▲Business Standard · 23/1/2026
Value Research · 3/1/2025
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.